Section: Partnerships and Cooperations

International Initiatives

Inria International Labs

• Fred Hutchinson Cancer center, Seattle;

• Baylor Institute for Immunology (Dallas);

• Duke University;

• Collaborations through clinical trials: NIH for the Prevac trial, NGO Alima for the Prevac trial, Several African clinical sites for Ebovac2 and Prevac trials;

• NIH program project grant "Revealing Reservoirs During Rebound", Harvard School of Public Health (HSPH) and the University of California, San Diego (P01AI131385, total budget $1.5M/yr for 5 years starting Oct 2017, both university manage the funding. Mélanie Prague is part of modelling unit of the "Quantitative Methods" research project (budget $220,000/yr). The principal investigator for this core is Victor de Grutolla (HSPH) The overall goal of this grant is to characterize viral rebound following antiretroviral therapy cessation in cohorts of patients who have started therapy early in infection, as well as in a cohort of terminally-ill patients who will interrupt therapy before death and subsequently donate their bodies to research.

• Project submitted by the Inria DYNMO-HIVE team with the laboratory “Program for evolutionary Dynamics” at Harvard (head Martin Nowak).

• Denis Agniel from the RAND Corporation on developing statistical methods for the analysis of RNA-seq data (Boris Hejblum).

• Tianxi Cai from Harvard University on developing methods for the linkage and analysis of Electronic Health Records data (Boris Hejblum).

• Katherine Liao from Harvard University on the analysis of Electronic Health Records data in the context of Rheumatoid Arthritis (Boris Hejblum).

• Machine learning team Data61 at CSIRO, Australia